Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells ...

Researchers from the Huntington's Disease Center, UCL Queen Square Institute of Neurology, and UK DRI at UCL have taken major ...

Neurofilament light (NFL) is a powerful and sensitive biomarker for tracking neuronal health and disease progression.

HACKENSACK, NJ / ACCESS Newswire / February 18, 2025 / Champions Oncology Inc. (NASDAQ:CSBR), a global leader in preclinical oncology research and clinical specialty testing, today announced the ...

Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Creative Diagnostics introduces comprehensive Vaccine Development CRO Services. NEW YORK, NY, UNITED STATES, February 22, 2025 /EINPresswir ...

Charles River Laboratories International Inc (NYSE:CRL) reported fourth-quarter 2024 revenue of $1 billion, a decrease of 1.1 ...

Using 3D bioprinting, researchers have developed a more effective method for testing potential HSV treatments.

The recommendations published in Nature Reviews Cancer are the result of a concerted focus by the Appendix Cancer ...

Analysts have set 12-month price targets for Charles River, revealing an average target of $185.0, a high estimate of $210.00 ...

Research Models and Services sales increased 4.3% ... release reinforced the view that Charles River remains the premier preclinical CRO, and the analyst is confident in its best-in-class offerings.